Solving Critical Data Challenges for Chemically-modified, Biologically-based Therapeutic Candidates www.biopharmaceuticalmedia.com Volume 4 Issue 2 – Summer – 2021 www.biopharmaceuticalmedia.com IBI – International Biopharmaceutical IndustryII INTERNATIONAL BIOPHARMACEUTICAL INDUSTRY Summer 2021 Volume 4 Issue 2 Research / Innovation / Development Adoption of Informatics Software As the modern drug discovery industry emerged over the latter half of the 20 th century, it was dominated by small molecule therapeutics. Vaccines and small peptide analogues were early biologics, and then in 1994 the first monoclonal antibody, Abciximab, was approved in the United States 2 . This was the landscape into which the widespread adoption of personal computers occurred in the final 15 or so y

Join for free to read